L’Institut mutualiste Montsouris est un établissement de santé privé d'intérêt collectif. Situé 42, boulevard Jourdan dans le 14ᵉ arrondissement de Paris.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at Institut Mutualiste Montsouris; Oncologie
During the past decade, Institut Mutualiste Montsouris; Oncologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy
2021-05-03
2027-11-22
Recruiting
520
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Institut Mutualiste Montsouris; Oncologie
According to Clinical.Site data, the most researched conditions in "Institut Mutualiste Montsouris; Oncologie" are
"Carcinoma, Transitional Cell" (1 trials), "Metastatic Prostate Cancer" (1 trials), "Muscle-invasive Bladder Cancer" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Institut Mutualiste Montsouris; Oncologie" in a lesser frequency.
Clinical Trials Intervention Types at Institut Mutualiste Montsouris; Oncologie
Most popular intervention types in "Institut Mutualiste Montsouris; Oncologie" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Placebo" (3 trials), "Abiraterone" (1 trials), "Ipatasertib" (1 trials) and "Prednisone/Prednisolone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Institut Mutualiste Montsouris; Oncologie
The vast majority of trials in "Institut Mutualiste Montsouris; Oncologie" are
3 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Institut Mutualiste Montsouris; Oncologie
Currently, there are NaN active trials in "Institut Mutualiste Montsouris; Oncologie".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Institut Mutualiste Montsouris; Oncologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institut Mutualiste Montsouris; Oncologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".